Stock Research: Fisher & Paykel Healthcare

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Fisher & Paykel Healthcare

NZSE:FPH NZFAPE0001S2
88
  • Value
    72
  • Growth
    67
  • Safety
    Safety
    15
  • Combined
    57
  • Sentiment
    68
  • 360° View
    360° View
    88
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Fisher & Paykel Healthcare Corporation Limited designs, manufactures, and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The company operates in the medical device industry, with products for hospital and homecare settings. It sells its products in over 120 countries worldwide, including Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, and India. In the last fiscal year, the company had a market cap of $12,544 million, profits of $722 million, revenue of $1,148 million, and 7506 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 88 (better than 88% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Fisher & Paykel Healthcare are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Fisher & Paykel Healthcare. The consolidated Growth Rank has a good rank of 67, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 67% of competitors in the same industry. The consolidated Safety Rank at 72 means that the company has a financing structure that is safer than 72% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 68, which means that professional investors are more optimistic about the stock than for 68% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 15, meaning that the share price of Fisher & Paykel Healthcare is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 85% of alternative stocks in the same industry. ...read more

more
Index
ASX 100
ASX 200
ASX 300
Human Rights
SDG 12
SDG 3
SDG 8
NZSX 50
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
15 13 26 19
Growth
67 99 49 33
Safety
Safety
72 75 73 59
Sentiment
68 46 58 37
360° View
360° View
88 78 59 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
21 7 3 19
Opinions Change
58 54 83 50
Pro Holdings
n/a 41 59 40
Market Pulse
85 83 83 69
Sentiment
68 46 58 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
15 13 26 19
Growth
67 99 49 33
Safety Safety
72 75 73 59
Combined
57 79 60 34
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
13 11 14 19
Price vs. Earnings (P/E)
5 3 7 13
Price vs. Book (P/B)
5 7 7 9
Dividend Yield
42 44 55 45
Value
15 13 26 19
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
80 77 78 10
Profit Growth
63 70 45 10
Capital Growth
25 98 19 95
Stock Returns
53 91 51 51
Growth
67 99 49 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
73 67 77 72
Refinancing
18 22 20 24
Liquidity
100 100 84 83
Safety Safety
72 75 73 59

Similar Stocks

Discover high‑ranked alternatives to Fisher & Paykel Healthcare and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

LG Uplus

KOSE:A032640
Country: South Korea
Industry: Integrated Telecommunication
Size: Medium
Full Stock Analysis

Hyundai Green Food

KOSE:A005440
Country: South Korea
Industry: Food Distributors
Size: Medium
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.